Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs142813158 | chr9:35654827 | C/T | 6.98E-7 | 176 | 15.37 | 16.37 | 3.43 | KM Plot |
| PAAD | rs142815773 | chr4:78449664 | G/A | 2.84E-5 | 177 | 15.57 | 14.63 | 3.9 | KM Plot |
| PAAD | rs143404897 | chr1:227578822 | G/A | 6.96E-5 | 176 | 15.4 | 16.45 | 3.9 | KM Plot |
| PAAD | rs143500987 | chr3:120856101 | AT/A | 1.3E-8 | 178 | 15.57 | 13.47 | 3.17 | KM Plot |
| PAAD | rs143532340 | chr1:227465729 | C/T | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs143737300 | chr19:49355038 | T/C | 1.22E-12 | 174 | 16.17 | 12.87 | 1.37 | KM Plot |
| PAAD | rs144024829 | chr4:78455351 | CA/C | 2.53E-5 | 178 | 15.57 | 14.63 | 3.9 | KM Plot |
| PAAD | rs144153593 | chr1:227514401 | C/CAGAT | 3.94E-5 | 176 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs144196911 | chr4:78442898 | T/A | 2.84E-5 | 177 | 15.57 | 14.63 | 3.9 | KM Plot |
| PAAD | rs144218379 | chr1:227464048 | G/C | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs144354067 | chr1:227467652 | G/A | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs144489696 | chr17:26956317 | AT/A | 2.29E-5 | 170 | 15.43 | 16.05 | 3.67 | KM Plot |
| PAAD | rs144491555 | chr19:49349025 | G/A | 8.54E-13 | 175 | 16.17 | 12.6 | 1.37 | KM Plot |
| PAAD | rs144515697 | chr1:16828961 | G/A | 1.17E-5 | 170 | 15.43 | 16.03 | 4.62 | KM Plot |
| PAAD | rs144562716 | chr1:227465624 | G/A | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |